CDK inhibitors: Cell cycle regulators and beyond

被引:893
作者
Besson, Arnaud [2 ]
Dowdy, Steven F. [3 ]
Roberts, James M. [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA
[2] Univ Toulouse, CNRS, LBCMCP, UMR5088, Toulouse, France
[3] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
关键词
D O I
10.1016/j.devcel.2008.01.013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
First identified as cell cycle inhibitors mediating the growth inhibitory cues of upstream signaling pathways, the cyclin-CDK inhibitors of the Cip/Kip family p21 Cip1, p27Kip1, and p57Kip2 have emerged as multifaceted proteins with functions beyond cell cycle regulation. In addition to regulating the cell cycle, Cip/Kip proteins play important roles in apoptosis, transcriptional regulation, cell fate determination, cell migration and cytoskeletal dynamics. A complex phosphorylation network modulates Cip/Kip protein functions by altering their subcellular localization, protein-protein interactions, and stability. These functions are essential for the maintenance of normal cell and tissue homeostasis, in processes ranging from embryonic development to tumor suppression.
引用
收藏
页码:159 / 169
页数:11
相关论文
共 143 条
[1]   Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2 [J].
Adkins, JN ;
Lumb, KJ .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 2002, 46 (01) :1-7
[2]   p21Cip1 promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export [J].
Alt, JR ;
Gladden, AB ;
Diehl, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) :8517-8523
[3]   Cdkn1c (p57Kip2) is the major regulator of embryonic growth within its imprinted domain on mouse distal chromosome 7 [J].
Andrews, Stuart C. ;
Wood, Michelle D. ;
Tunster, Simon J. ;
Barton, Sheila C. ;
Surani, M. Azim ;
John, Rosalind M. .
BMC DEVELOPMENTAL BIOLOGY, 2007, 7
[4]   Induction of p57KIP2 expression by p73β [J].
Bálint, É ;
Phillips, AC ;
Kozlov, S ;
Stewart, CL ;
Vousden, KH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :3529-3534
[5]   p27Kip1 modulates cell migration through the regulation of RhoA activation [J].
Besson, A ;
Gurian-West, M ;
Schmidt, A ;
Hall, A ;
Roberts, JM .
GENES & DEVELOPMENT, 2004, 18 (08) :862-876
[6]   A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression [J].
Besson, A ;
Gurian-West, M ;
Chen, XY ;
Kelly-Spratt, KS ;
Kemp, CJ ;
Roberts, JM .
GENES & DEVELOPMENT, 2006, 20 (01) :47-64
[7]   Regulation of the cytoskeleton: An oncogenic function for CDK inhibitors? [J].
Besson, A ;
Assoian, RK ;
Roberts, JM .
NATURE REVIEWS CANCER, 2004, 4 (12) :948-955
[8]   Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype [J].
Besson, Arnaud ;
Hwang, Harry C. ;
Cicero, Samantha ;
Donovan, Stacy L. ;
Gurian-West, Mark ;
Johnson, Dianna ;
Clurman, Bruce E. ;
Dyer, Michael A. ;
Roberts, James M. .
GENES & DEVELOPMENT, 2007, 21 (14) :1731-1746
[9]   Functional analysis of the p57KIP2 gene mutation in Beckwith-Wiedemann syndrome [J].
Bhuiyan, ZA ;
Yatsuki, H ;
Sasaguri, T ;
Joh, K ;
Soejima, H ;
Zhu, XK ;
Hatada, I ;
Morisaki, H ;
Morisaki, T ;
Mukai, T .
HUMAN GENETICS, 1999, 104 (03) :205-210
[10]  
Biankin AV, 2001, CANCER RES, V61, P8830